KOR

e-Article

Publication date
-
(ex : 2010-2015)
'e-Article' searched 25results | List 1~10
Electronic Resource
Hilberink, Jacobien R; van Zeventer, Isabelle A; Chitu, Dana A; Pabst, Thomas; Klein, Saskia K; Stussi, Georg; Griskevicius, Laimonas; Valk, Peter J M; Cloos, Jacqueline; van de Loosdrecht, Arjan A; Breems, Dimitri; van Lammeren-Venema, Danielle; Boersma, Rinske; Jongen-Lavrencic, Mojca; Fehr, Martin; Hoogendoorn, Mels; Manz, Markus G; Söhne, Maaike; van Marwijk Kooy, Rien; Deeren, Dries; van der Poel, Marjolein W M; Legdeur, Marie Cecile; Tick, Lidwine; Chalandon, Yves; Ammatuna, Emanuele; Blum, Sabine; Löwenberg, Bob; Ossenkoppele, Gert J; Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON); Swiss Group for Clinical Cancer Research (SAKK); et al (2023). Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine. Blood Cancer Journal, 13(1):93.
Electronic Resource
Huls, Gerwin; Chitu, Dana A; Pabst, Thomas; Klein, Saskia K; Stussi, Georg; Griskevicius, Laimonas; Valk, Peter J M; Cloos, Jacqueline; van de Loosdrecht, Arjan A; Breems, Dimitri; van Lammeren-Venema, Danielle; van Zeventer, Isabelle; Boersma, Rinske; Jongen-Lavrencic, Mojca; Fehr, Martin; Hoogendoorn, Mels; Manz, Markus G; Söhne, Maaike; van Marwijk Kooy, Rien; Deeren, Dries; van der Poel, Marjolein W M; Legdeur, Marie Cecile; Tick, Lidwine; Chalandon, Yves; Ammatuna, Emanuele; Blum, Sabine; Löwenberg, Bob; Ossenkoppele, Gert J (2020). Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS. Blood Advances, 4(18):4267-4277.
Refining the search results
Facets
[AR] Chitu, Dana A
Publication year
-
Database provider
Title
Publisher
자료유형(Source Type)
Language